Last reviewed · How we verify

Height-adjusted dose of bupivacaine

Bartosz Horosz, MD · Phase 1 active Small molecule

Height-adjusted dose of bupivacaine is a Small molecule drug developed by Bartosz Horosz, MD. It is currently in Phase 1 development.

At a glance

Generic nameHeight-adjusted dose of bupivacaine
SponsorBartosz Horosz, MD
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Height-adjusted dose of bupivacaine

What is Height-adjusted dose of bupivacaine?

Height-adjusted dose of bupivacaine is a Small molecule drug developed by Bartosz Horosz, MD.

Who makes Height-adjusted dose of bupivacaine?

Height-adjusted dose of bupivacaine is developed by Bartosz Horosz, MD (see full Bartosz Horosz, MD pipeline at /company/bartosz-horosz-md).

What development phase is Height-adjusted dose of bupivacaine in?

Height-adjusted dose of bupivacaine is in Phase 1.

Related